Your browser doesn't support javascript.
loading
Cytotoxic CD4+ T Cells in Bladder Cancer-A New License to Kill.
Sacher, Adrian G; St Paul, Michael; Paige, Christopher J; Ohashi, Pamela S.
Afiliação
  • Sacher AG; Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto, ON M5G 2M9, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • St Paul M; Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto, ON M5G 2M9, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Paige CJ; Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto, ON M5G 2M9, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Ohashi PS; Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto, ON M5G 2M9, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: pam.ohashi@uhnresearch.ca.
Cancer Cell ; 38(1): 28-30, 2020 07 13.
Article em En | MEDLINE | ID: mdl-32663467
ABSTRACT
CD4+ T cells with cytotoxic capability are increasingly recognized as potentially key actors in anti-tumor immunity. A new report in Cell elucidates the presence and potential role of a population of cytotoxic CD4+ T cells in bladder cancer using single cell sequencing technology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos T CD4-Positivos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos T CD4-Positivos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article